| pubmed-article:11163469 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11163469 | lifeskim:mentions | umls-concept:C0012634 | lld:lifeskim |
| pubmed-article:11163469 | lifeskim:mentions | umls-concept:C0305065 | lld:lifeskim |
| pubmed-article:11163469 | lifeskim:mentions | umls-concept:C0042196 | lld:lifeskim |
| pubmed-article:11163469 | lifeskim:mentions | umls-concept:C0010181 | lld:lifeskim |
| pubmed-article:11163469 | lifeskim:mentions | umls-concept:C0010186 | lld:lifeskim |
| pubmed-article:11163469 | lifeskim:mentions | umls-concept:C0220812 | lld:lifeskim |
| pubmed-article:11163469 | pubmed:dateCreated | 2001-2-22 | lld:pubmed |
| pubmed-article:11163469 | pubmed:abstractText | Objective: To review studies of the costs of pneumococcal disease and the cost effectiveness of pneumococcal conjugate vaccination conducted in association with the Kaiser Permanente Pneumococcal conjugate Efficacy Trial. Results: for each birth cohort of 3.8 million infants, routine pneumococcal conjugate vaccination program for healthy infants would prevent more than 12000 (78% of potential) meningitis and bacteremia cases, 53000 (69% of potential) pneumonia cases, and 1 million (8% of potential) otitis media episodes. Before accounting for vaccine costs, the vaccination program would reduce the costs of pneumococcal disease by $342 million in medical and $415 million in work-loss and other costs. Vaccination of healthy infants would result in net savings for society if the vaccine cost less than $46 per dose, and net savings for the health care payer if the vaccine cost less than $18 per dose. | lld:pubmed |
| pubmed-article:11163469 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11163469 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11163469 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11163469 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11163469 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11163469 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11163469 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11163469 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:11163469 | pubmed:issn | 0264-410X | lld:pubmed |
| pubmed-article:11163469 | pubmed:author | pubmed-author:RaoG JGJ | lld:pubmed |
| pubmed-article:11163469 | pubmed:author | pubmed-author:ShinefieldH... | lld:pubmed |
| pubmed-article:11163469 | pubmed:author | pubmed-author:CapraAA | lld:pubmed |
| pubmed-article:11163469 | pubmed:author | pubmed-author:BlackSS | lld:pubmed |
| pubmed-article:11163469 | pubmed:author | pubmed-author:LieuT ATA | lld:pubmed |
| pubmed-article:11163469 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11163469 | pubmed:day | 8 | lld:pubmed |
| pubmed-article:11163469 | pubmed:volume | 19 Suppl 1 | lld:pubmed |
| pubmed-article:11163469 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11163469 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11163469 | pubmed:pagination | S83-6 | lld:pubmed |
| pubmed-article:11163469 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11163469 | pubmed:meshHeading | pubmed-meshheading:11163469... | lld:pubmed |
| pubmed-article:11163469 | pubmed:meshHeading | pubmed-meshheading:11163469... | lld:pubmed |
| pubmed-article:11163469 | pubmed:meshHeading | pubmed-meshheading:11163469... | lld:pubmed |
| pubmed-article:11163469 | pubmed:meshHeading | pubmed-meshheading:11163469... | lld:pubmed |
| pubmed-article:11163469 | pubmed:meshHeading | pubmed-meshheading:11163469... | lld:pubmed |
| pubmed-article:11163469 | pubmed:meshHeading | pubmed-meshheading:11163469... | lld:pubmed |
| pubmed-article:11163469 | pubmed:meshHeading | pubmed-meshheading:11163469... | lld:pubmed |
| pubmed-article:11163469 | pubmed:meshHeading | pubmed-meshheading:11163469... | lld:pubmed |
| pubmed-article:11163469 | pubmed:meshHeading | pubmed-meshheading:11163469... | lld:pubmed |
| pubmed-article:11163469 | pubmed:meshHeading | pubmed-meshheading:11163469... | lld:pubmed |
| pubmed-article:11163469 | pubmed:meshHeading | pubmed-meshheading:11163469... | lld:pubmed |
| pubmed-article:11163469 | pubmed:meshHeading | pubmed-meshheading:11163469... | lld:pubmed |
| pubmed-article:11163469 | pubmed:meshHeading | pubmed-meshheading:11163469... | lld:pubmed |
| pubmed-article:11163469 | pubmed:meshHeading | pubmed-meshheading:11163469... | lld:pubmed |
| pubmed-article:11163469 | pubmed:meshHeading | pubmed-meshheading:11163469... | lld:pubmed |
| pubmed-article:11163469 | pubmed:meshHeading | pubmed-meshheading:11163469... | lld:pubmed |
| pubmed-article:11163469 | pubmed:meshHeading | pubmed-meshheading:11163469... | lld:pubmed |
| pubmed-article:11163469 | pubmed:meshHeading | pubmed-meshheading:11163469... | lld:pubmed |
| pubmed-article:11163469 | pubmed:meshHeading | pubmed-meshheading:11163469... | lld:pubmed |
| pubmed-article:11163469 | pubmed:meshHeading | pubmed-meshheading:11163469... | lld:pubmed |
| pubmed-article:11163469 | pubmed:meshHeading | pubmed-meshheading:11163469... | lld:pubmed |
| pubmed-article:11163469 | pubmed:meshHeading | pubmed-meshheading:11163469... | lld:pubmed |
| pubmed-article:11163469 | pubmed:meshHeading | pubmed-meshheading:11163469... | lld:pubmed |
| pubmed-article:11163469 | pubmed:meshHeading | pubmed-meshheading:11163469... | lld:pubmed |
| pubmed-article:11163469 | pubmed:meshHeading | pubmed-meshheading:11163469... | lld:pubmed |
| pubmed-article:11163469 | pubmed:meshHeading | pubmed-meshheading:11163469... | lld:pubmed |
| pubmed-article:11163469 | pubmed:meshHeading | pubmed-meshheading:11163469... | lld:pubmed |
| pubmed-article:11163469 | pubmed:meshHeading | pubmed-meshheading:11163469... | lld:pubmed |
| pubmed-article:11163469 | pubmed:meshHeading | pubmed-meshheading:11163469... | lld:pubmed |
| pubmed-article:11163469 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:11163469 | pubmed:articleTitle | Assessing costs and cost effectiveness of pneumococcal disease and vaccination within Kaiser Permanente. | lld:pubmed |
| pubmed-article:11163469 | pubmed:affiliation | Kaiser Permanente Vaccine Study Center, 1 Kaiser Plaze-16th floor, Oakland, CA 94612, USA. steve.black@kp.org | lld:pubmed |
| pubmed-article:11163469 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11163469 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11163469 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:11163469 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:11163469 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11163469 | lld:pubmed |
